“…The discovery of metathesis reactions has allowed the noticeable expansion of possibilities for the transformation of different unsaturated substrates, including those aimed at obtaining complex naturally occurring compounds and pharmacologically meaningful molecules, which is reflected in a number of recent reviews [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 ]. In particular, the ring-rearrangement metathesis (RRM) of bi- and polycyclic alkenes has made it possible to obtain systems that are practically inaccessible by means of other synthetic pathways [ 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ]. Most often, for the rearrangement of bridged alkenes, the commercially available Grubbs (G) and Hoveyda–Grubbs (HG) ruthenium catalysts are used, which permits the reliable production of scaffolds possessing a wide range of potential biological activity due to the characteristics of their carbon skeletons [ 19 , 20 , 21 , 22 , 23 ].…”